Israeli - Kiingereza - Ministry of Health

cure medical & technical supply - acetic acid 5.6 ml/l; arginine 8.4 g/l - solution for infusion - amino acids - vamin 14ef is indicated as a source of amino acids for protein synthesis in patients needing intravenous nutrition. vamin 14ef is particulary suitable for patients with moderaterly increased amino acid requirements.

Marekani - Kiingereza - NLM (National Library of Medicine)

a-s medication solutions - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 20.65 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal. safety and effectiveness in pediatric patients below the age of 3 years have not been established.

Marekani - Kiingereza - NLM (National Library of Medicine)

unit dose services - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 20 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid otic solution or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine, quantity: 14 g/l; arginine, quantity: 12 g/l; glycine, quantity: 11 g/l; histidine, quantity: 3 g/l; isoleucine, quantity: 5 g/l; leucine, quantity: 7.4 g/l; lysine acetate, quantity: 9.31 g/l (equivalent: lysine, qty 6.6 g/l); methionine, quantity: 4.3 g/l; phenylalanine, quantity: 5.1 g/l; proline, quantity: 11.2 g/l; serine, quantity: 6.5 g/l; taurine, quantity: 1 g/l; threonine, quantity: 4.4 g/l; tryptophan, quantity: 2 g/l; tyrosine, quantity: 400 mg/l; valine, quantity: 6.2 g/l - injection, solution - excipient ingredients: glacial acetic acid; water for injections - to supply amino acids as part of a composite admixture of total parenteral nutrition.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine, quantity: 14 g/l; arginine, quantity: 12 g/l; glycine, quantity: 11 g/l; histidine, quantity: 3 g/l; isoleucine, quantity: 5 g/l; leucine, quantity: 7.4 g/l; lysine acetate, quantity: 9.31 g/l (equivalent: lysine, qty 6.6 g/l); methionine, quantity: 4.3 g/l; phenylalanine, quantity: 5.1 g/l; proline, quantity: 11.2 g/l; serine, quantity: 6.5 g/l; taurine, quantity: 1 g/l; threonine, quantity: 4.4 g/l; tryptophan, quantity: 2 g/l; tyrosine, quantity: 400 mg/l; valine, quantity: 6.2 g/l - injection, solution - excipient ingredients: glacial acetic acid; water for injections - to supply amino acids as part of a composite admixture of total parenteral nutrition.

Marekani - Kiingereza - NLM (National Library of Medicine)

a-s medication solutions - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 20 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid otic solution or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Singapoo - Kiingereza - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - aminoacetic acid (glycine); l-alanine; l-arginine; l-histidine; l-isoleucine; l-leucine; l-lysine hcl eqv l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; l-threonine; l-tryptophan; l-tyrosine; l-valine - injection - 10.30 g/l - aminoacetic acid (glycine) 10.30 g/l; l-alanine 20.70 g/l; l-arginine 11.50 g/l; l-histidine 4.80 g/l; l-isoleucine 6.00 g/l; l-leucine 7.30 g/l; l-lysine hcl eqv l-lysine 5.80 g/l; l-methionine 4.00 g/l; l-phenylalanine 5.60 g/l; l-proline 6.80 g/l; l-serine 5.00 g/l; l-threonine 4.20 g/l; l-tryptophan 1.80 g/l; l-tyrosine 0.40 g/l; l-valine 5.80 g/l

Marekani - Kiingereza - NLM (National Library of Medicine)

akorn operating company llc - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - acetic acid 20.75 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation. hypersensitivity to hydrocortisone and acetic acid or any of the ingredients; herpes simplex, vaccinia and varicella. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Marekani - Kiingereza - NLM (National Library of Medicine)

bausch & lomb incorporated - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 2 mg in 1 ml

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - leucine, quantity: 4.02 g/l; phenylalanine, quantity: 3.08 g/l; methionine, quantity: 2.2 g/l; lysine hydrochloride, quantity: 3.99 g/l (equivalent: lysine, qty 3.19 g/l); isoleucine, quantity: 3.3 g/l; valine, quantity: 3.19 g/l; histidine, quantity: 2.64 g/l; threonine, quantity: 2.31 g/l; tryptophan, quantity: 990 mg/l; alanine, quantity: 11.4 g/l; glycine, quantity: 5.66 g/l; arginine, quantity: 6.32 g/l; proline, quantity: 3.74 g/l; tyrosine, quantity: 220 mg/l; serine, quantity: 2.75 g/l; sodium aceta - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)